Visiomed Group SA (ALVMG) | Financial Analysis & Statements
Visiomed Group SA | Small_cap | Healthcare
Visiomed Group SA | Small_cap | Healthcare
Financial Overview
Latest Annual: 2023Income Metrics
Revenue
13.7M
Gross Profit
6.3M
45.95%
Operating Income
952.0K
6.95%
Net Income
902.0K
6.58%
EPS (Diluted)
€0.00
Balance Sheet Metrics
Total Assets
36.6M
Total Liabilities
11.8M
Shareholders Equity
24.7M
Debt to Equity
0.48
Cash Flow Metrics
Operating Cash Flow
-1.3M
Free Cash Flow
-1.5M
Revenue & Profitability Trend
Visiomed Group SA Income Statement From 2020 to 2023
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 13.7M | 14.4M | 7.2M | 19.0M |
| Cost of Goods Sold | 7.4M | 11.2M | 7.9M | 22.7M |
| Gross Profit | 6.3M | 3.2M | -715.0K | -3.8M |
| Operating Expenses | 23.0K | 801.0K | 832.0K | -786.0K |
| Operating Income | 952.0K | -3.9M | -3.7M | -6.6M |
| Pre-tax Income | 1.5M | -5.1M | -4.2M | -5.2M |
| Income Tax | -37.0K | 113.0K | 142.0K | -164.0K |
| Net Income | 902.0K | -5.3M | -4.5M | -5.2M |
| EPS (Diluted) | €0.00 | -€0.02 | -€0.03 | -€0.20 |
Income Statement Trend
Visiomed Group SA Balance Sheet From 2019 to 2023
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 5.3M | 7.0M | 16.0M | 5.1M | - |
| Non-Current Assets | 31.3M | 29.1M | 28.1M | 832.0K | - |
| Total Assets | 36.6M | 36.1M | 44.1M | 5.9M | - |
| Liabilities | |||||
| Current Liabilities | 3.4M | 5.5M | 19.3M | 8.8M | - |
| Non-Current Liabilities | 8.5M | 6.3M | 10.7M | 1.5M | - |
| Total Liabilities | 11.8M | 11.8M | 30.0M | 10.3M | - |
| Equity | |||||
| Total Shareholders Equity | 24.7M | 24.3M | 14.1M | -4.4M | - |
Balance Sheet Composition
Visiomed Group SA Cash Flow Statement From 2020 to 2023
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | 902.0K | -5.3M | -4.5M | -5.2M |
| Operating Cash Flow | -1.3M | -5.3M | -4.5M | -5.2M |
| Investing Activities | ||||
| Capital Expenditures | -1.8M | -5.5M | -171.0K | 3.1M |
| Investing Cash Flow | -1.6M | -17.5M | -15.0M | 3.1M |
| Financing Activities | ||||
| Dividends Paid | - | - | - | - |
| Financing Cash Flow | 1.0M | 14.8M | 27.2M | 0 |
| Free Cash Flow | -1.5M | -7.3M | -6.7M | -11.1M |
Cash Flow Trend
Visiomed Group SA Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
57.80
Forward P/E
5.75
Price to Book
2.10
Price to Sales
3.88
PEG Ratio
5.75
Profitability Ratios
Profit Margin
6.58%
Operating Margin
6.76%
Return on Equity
3.68%
Return on Assets
0.68%
Financial Health
Current Ratio
0.49
Debt to Equity
32.03
Beta
-0.62
Per Share Data
EPS (TTM)
€0.00
Book Value per Share
€0.08
Revenue per Share
€0.05
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| alvmg | 53.2M | 57.80 | 2.10 | 3.68% | 6.58% | 32.03 |
| Amplitude Surgical | 295.0M | 307.50 | 3.12 | 1.15% | 1.00% | 126.32 |
| Crossject S.A | 80.5M | - | - | 478.68% | 0.00% | -7.88 |
| Bonyf N.V | 8.2M | - | 18.85 | -38.97% | 8.54% | 0.00 |
| Spineway S.A | 3.9M | 0.02 | 0.07 | -17.85% | -30.35% | 7.50 |
| I.Ceram S.A | 155.7K | 9.88 | 0.46 | -124.00% | -170.02% | 476.65 |
Financial data is updated regularly. All figures are in the company's reporting currency.